RT Journal Article
SR Electronic
T1 1189 Elucidating the effects of chemotherapy and immune checkpoint blockade on the activity of tarlatamab, a DLL3-targeting bispecific T cell engager molecule, in small cell lung cancer preclinical models
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1309
OP A1309
DO 10.1136/jitc-2023-SITC2023.1189
VO 11
IS Suppl 1
A1 You, Ran
A1 Estrada, Juan
A1 Zhan, Jinghui
A1 Deegen, Petra
A1 Cooke, Keegan
A1 Friedrich, Matthias
A1 Bailis, Julie M
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1309.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.